The Leesburg, Va.-based company said it also expects to grant initial note buyers an option to purchase an additional $10 million worth of the notes during a 13-day period beginning the first day it issues the notes.
Notes offered in the round will mature on June 30, 2025, unless converted, redeemed or repurchased earlier than that date, K2M said.
Net proceeds from the offering will be used to repay approximately $18 million in borrowings under the company’s revolving credit facility, while remaining funds will support general corporate purposes, according to a press release.
Last month, K2M said it launched the Mojave PL 3D expandable interbody system featuring its lamellar 3D titanium technology.
These featured panels at DeviceTalks Boston will explore the state of R&D at major medtech firms, as well as the latest trends when it comes to developing combination products, neuromodulation devices, robotic systems and women's health technology.
View Technology Track Featured Sessions
Register today to save. Use code TECHTRACK to save an additional 10%.